Michelle A. Collins

561 total citations
14 papers, 399 citations indexed

About

Michelle A. Collins is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Michelle A. Collins has authored 14 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Psychiatry and Mental health and 3 papers in Pharmacology. Recurrent topics in Michelle A. Collins's work include Pharmacological Effects and Toxicity Studies (6 papers), Bipolar Disorder and Treatment (4 papers) and Hepatitis C virus research (3 papers). Michelle A. Collins is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Bipolar Disorder and Treatment (4 papers) and Hepatitis C virus research (3 papers). Michelle A. Collins collaborates with scholars based in United States, United Kingdom and Canada. Michelle A. Collins's co-authors include Robert N. Hughes, Charles L. Bowden, Patricia J. Wozniak, Joseph R. Calabrese, Alan C. Swann, Walid Abi‐Saab, Mario Saltarelli, Debra K. Towle, Michael C. Smith and Kirsten Michelsen and has published in prestigious journals such as Hepatology, Radiology and British Journal of Cancer.

In The Last Decade

Michelle A. Collins

14 papers receiving 382 citations

Peers

Michelle A. Collins

PMH

PPCH

CMN

Joshua Burke United States

Miho Tanaka Japan

C Schumann Germany

Renato D’Alonzo Italy

Hepsen Mine Serin Türkiye

A. Chisari Argentina

Bing Gao China

Xiwen Hu China

T. Lerman‐Sagie Israel

T. Wiegman Netherlands

Joshua Burke United States

Michelle A. Collins

285 ×1.5

PMH

27 ×0.3

PPCH

45 ×0.7

247 ×4.8

79 ×2.0

CMN

Citations per year, relative to Michelle A. Collins Michelle A. Collins (= 1×) peers Joshua Burke

Countries citing papers authored by Michelle A. Collins

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Collins more than expected).

Fields of papers citing papers by Michelle A. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Collins. The network helps show where Michelle A. Collins may publish in the future.

Co-authorship network of co-authors of Michelle A. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Collins. A scholar is included among the top collaborators of Michelle A. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Collins. Michelle A. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pol, Stanislas, Alexander Thompson, Michelle A. Collins, et al.. (2024). Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Hepatology. 81(3). 1006–1018. 2 indexed citations

Mukherjee, Dwaipayan, Michelle A. Collins, Douglas E. Dylla, et al.. (2023). Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations. Infectious Diseases and Therapy. 12(8). 2057–2070. 3 indexed citations

Brown, Robert S., Michelle A. Collins, Simone I. Strasser, et al.. (2022). Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension. Infectious Diseases and Therapy. 11(2). 913–924. 1 indexed citations

Mowbray, Charles E., Andrew Bell, Michelle A. Collins, et al.. (2011). Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: A novel histamine H4 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(21). 6596–6602. 29 indexed citations

Apostol, George, Walid Abi‐Saab, Christopher J. Kratochvil, et al.. (2011). Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology. 219(3). 715–725. 42 indexed citations

Sala, Evis, Masako Kataoka, Neeta Pandit‐Taskar, et al.. (2010). Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival. Radiology. 257(1). 125–134. 55 indexed citations

Hirschfeld, Robert M. A., et al.. (2010). A Randomized, Placebo-Controlled, Multicenter Study of Divalproex Sodium Extended-Release in the Acute Treatment of Mania. The Journal of Clinical Psychiatry. 71(4). 426–432. 18 indexed citations

Hughes, Robert N. & Michelle A. Collins. (2009). Enhanced habituation and decreased anxiety by environmental enrichment and possible attenuation of these effects by chronic α-tocopherol (vitamin E) in aging male and female rats. Pharmacology Biochemistry and Behavior. 94(4). 534–542. 42 indexed citations

McElroy, Susan L., Charles L. Bowden, Michelle A. Collins, et al.. (2007). Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. Journal of Affective Disorders. 107(1-3). 127–133. 10 indexed citations

10.

Bowden, Charles L., Alan C. Swann, Joseph R. Calabrese, et al.. (2006). A Randomized, Placebo-Controlled, Multicenter Study of Divalproex Sodium Extended Release in the Treatment of Acute Mania. The Journal of Clinical Psychiatry. 67(10). 1501–1510. 87 indexed citations

11.

Bowden, Charles L., Michelle A. Collins, Susan L. McElroy, et al.. (2005). Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo. Neuropsychopharmacology. 30(10). 1932–1939. 36 indexed citations

12.

Smith, Michael C., Franca Centorrino, Jeffrey A. Welge, & Michelle A. Collins. (2004). Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials. Epilepsy & Behavior. 5(5). 746–751. 34 indexed citations

13.

Collins, Michelle A., Derek J. Hodgson, Kirsten Michelsen, & Debra K. Towle. (1987). Synthesis and characterization of the binuclear complex di-µ-oxo-bis[N,N′-bis(2-methylpyridyl)ethane-1,2-diamine]dimanganese(III,IV)perchlorate trihydrate,[(bispicen)MnO]₂(ClO₄)₃·3H₂O. Journal of the Chemical Society Chemical Communications. 1659–1660. 34 indexed citations

14.

Collins, Michelle A. & K. Hellmann. (1982). Histamine receptor antagonism and anti-tumour activity. British Journal of Cancer. 46(5). 817–820. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact